BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31736281)

  • 1. Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancer.
    Ohmura H; Ito M; Uchino K; Okada C; Tanishima S; Yamada Y; Momosaki S; Komoda M; Kuwayama M; Yamaguchi K; Okumura Y; Nakano M; Tsuchihashi K; Isobe T; Ariyama H; Kusaba H; Oda Y; Akashi K; Baba E
    FEBS Open Bio; 2020 Jan; 10(1):147-157. PubMed ID: 31736281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
    Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas.
    Okada T; Nakamura M; Nishikawa J; Sakai K; Zhang Y; Saito M; Morishige A; Oga A; Sasaki K; Suehiro Y; Hinoda Y; Sakaida I
    Cancer Sci; 2013 Oct; 104(10):1309-14. PubMed ID: 23829175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
    Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
    Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
    Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
    Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
    Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
    Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer.
    Harada H; Soeno T; Yokoi K; Nishizawa N; Ushiku H; Hosoda K; Hiki N; Yamashita K
    J Surg Res; 2020 Dec; 256():404-412. PubMed ID: 32777557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and gastric carcinoma.
    Fukayama M
    Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
    Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
    Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
    Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
    Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.
    Vo QN; Geradts J; Gulley ML; Boudreau DA; Bravo JC; Schneider BG
    J Clin Pathol; 2002 Sep; 55(9):669-75. PubMed ID: 12194996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
    Kim J; Lee HS; Bae SI; Lee YM; Kim WH
    Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
    Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
    Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative approach identified genes associated with drug response in gastric cancer.
    Zhou J; Yong WP; Yap CS; Vijayaraghavan A; Sinha RA; Singh BK; Xiu S; Manesh S; Ngo A; Lim A; Ang C; Xie C; Wong FY; Lin SJ; Wan WK; Tan IB; Flotow H; Tan P; Lim KH; Yen PM; Goh LK
    Carcinogenesis; 2015 Apr; 36(4):441-51. PubMed ID: 25742747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma.
    Liu X; Wang Y; Wang X; Sun Z; Li L; Tao Q; Luo B
    Arch Virol; 2013 Jan; 158(1):123-32. PubMed ID: 23001722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy: Case Report.
    Yanai H; Yahara N; Furuya T; Hayashi H; Murakami T; Shimokawa Y; Sugihara S
    J Gastrointest Cancer; 2016 Mar; 47(1):107-10. PubMed ID: 25972063
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
    Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
    Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.